↓ Skip to main content

Cochrane Database of Systematic Reviews

Cannabinoids for epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, March 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Citations

dimensions_citation
159 Dimensions

Readers on

mendeley
528 Mendeley
Title
Cannabinoids for epilepsy
Published in
Cochrane database of systematic reviews, March 2014
DOI 10.1002/14651858.cd009270.pub3
Pubmed ID
Authors

David Gloss, Barbara Vickrey

Abstract

Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 528 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 <1%
United Kingdom 2 <1%
Brazil 1 <1%
Puerto Rico 1 <1%
Peru 1 <1%
Unknown 518 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 108 20%
Student > Master 69 13%
Researcher 68 13%
Other 43 8%
Student > Ph. D. Student 39 7%
Other 90 17%
Unknown 111 21%
Readers by discipline Count As %
Medicine and Dentistry 154 29%
Pharmacology, Toxicology and Pharmaceutical Science 46 9%
Agricultural and Biological Sciences 36 7%
Psychology 33 6%
Neuroscience 33 6%
Other 94 18%
Unknown 132 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 148. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#280,044
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#465
of 11,499 outputs
Outputs of similar age
#2,281
of 236,041 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 218 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.